Tofacitinib citrate 540737-29-9 Rheumatoid mob caj dab Anticancer
Kev Them Nyiaj:T / T, L / C
Khoom Keeb Kwm:Tuam Tshoj
Shipping Chaw nres nkoj:Beijing / Shanghai / Hangzhou
Muaj peev xwm ntau lawm:100kg / hli
Order (MOQ):25kg ua
Lub Sijhawm Lead:3 Hnub Ua Haujlwm
Kev cia khoom:Khaws rau hauv qhov chaw txias, qhuav, chav sov.
Cov khoom siv pob:nruas
Pob loj:25kg ua/nruas
Cov ntaub ntawv kev nyab xeeb:Tsis yog khoom txaus ntshai
Taw qhia
Tofacitinib, yog ib qho tshuaj siv los kho mob rheumatoid mob caj dab, psoriatic mob caj dab, thiab ulcerative colitis.
Tofacitinib citrate yog siv los kho cov neeg laus uas muaj mob nruab nrab mus rau mob rheumatoid mob caj dab uas muaj cov lus teb tsis txaus rau, lossis leej twg intolerant ntawm, methotrexate.
Tofacitinib citrate yog qhia rau kev kho mob ntawm nruab nrab mus rau hnyav rheumatoid mob caj dab (RA) nyob rau hauv cov neeg laus uas tau teb tsis txaus rau, los yog leej twg intolerant rau ib los yog ntau yam kab mob-hloov tshuaj antirheumatic.
Specification (hauv tsev)
| Yam khoom | Specification |
| Qhov tshwm sim | Dawb los yog tawm-dawb crystalline hmoov |
| Kev txheeb xyuas | IR, HPLC |
| Dej | ≤ 1.5% |
| Yam khoom muaj feem | TOFA 06 ≤ 0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib dehydrogenated ≤0.15% | |
| Txhua yam tsis paub impurity ≤0.10% | |
| Tag nrho cov impurities: ≤1.0% | |
| Residual Solvents | Ethanol ≤5000ppm |
| Benzene ≤2ppm | |
| Toluene ≤890ppm | |
| Chlroroethane ≤1000ppm | |
| N, N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| Sulfated tshauv | ≤0.1% |
| Hnyav Hlau | ≤10ppm |
| Chrial HPLC | 3S, 4S tofacitinib ≤0.15% |
| Assay (raws li anhydrous hauv paus) 98.0-102.0% |
